Syndecan-1 (Sdc1) plays a major role in wound healing and modulates inflammatory responses. Sdc1 expression is reduced in lesions of patients with ulcerative colitis. The aim of this study was to investigate the role of Sdc1 in murine dextran sodium sulfate (DSS)-induced colitis. DSS colitis was induced in Sdc1-deficient (knockout (KO)) and wild-type mice by oral administration of 3% DSS. KO mice exhibited a significantly increased lethality as compared with wild-type controls (61 versus 5% , P < 0.05). Impaired mucosal healing and prolonged recruitment of inflammatory cells in KO mice were accompanied by significant up-regulation of tumor necrosis factor-␣, CC chemokine ligand 3/macrophage inflammatory protein-1␣, and vascular cell adhesion molecule-1 , as determined by histological correlation between 0 and 15 days after colitis induction , TaqMan low-density array analysis , and quantitative real-time PCR. Treatment from days 7 through 14 with enoxaparin , a functional analogue of the Sdc1 heparan sulfate chains , significantly reduced lethality of KO mice due to DSS-induced colitis , which was correlated with improved mucosal healing. In vitro, Sdc1-deficient polymorphonuclear cells displayed increased adhesion to endothelial cells and intercellular adhesion molecule-1, and enoxaparin reverted adhesion to wild-type levels. Small interfering RNA-mediated knockdown of Sdc1 expression resulted in reduced basic fibroblast growth factor-mediated mitogen-activated protein kinase signaling and reduced Caco-2 cell proliferation. We conclude that Sdc1 has a protective effect during experimental colitis. The modification of missing Sdc1 function by heparin analogues may emerge as a promising anti-inflammatory approach. (Am J Pathol

Heparan sulfate 3-O-sulfotransferase 2 (HS3ST2), an enzyme mediating 3-O-sulfation of heparan sulfate (HS), is silenced by hypermethylation in breast cancer. As HS has an important co-receptor function for numerous signal transduction pathways, the phenotypical changes due to HS3ST2 reexpression were investigated in vitro using high and low invasive breast cancer cell lines. Compared to controls, highly invasive HS3ST2-expressing MDA-MB-231 cells showed enhanced Matrigel invasiveness, transendothelial migration and motility. Affymetrix screening and confirmatory real-time PCR and Western blotting analysis revealed increased expression of several matrix metalloproteinases, cadherin-11, E-cadherin and CEACAM-1, while protease inhibitor and annexin A10 expression were decreased. Low invasive HS3ST2 -expressing MCF-7 cells became even less invasive, with no change in gelatinolytic MMP activity. HS3ST2 expression increased HS-dependent basal and FGF2-specific signaling through the constitutively active p44/42 MAPK pathway in MDA-MB-231 cells. Increased MAPK activation was accompanied by upregulation of ß-catenin in MDA-MB-231, and of the transcription factor Tcf4 in both cell lines. Dysregulation of Tcf4-regulated ion transporters and increased cytosolic acidification were observed in HS3ST2-expressing MDA-MB-231 cells, which is a possible underlying cause of increased chemosensitivity towards doxorubicine and paclitaxel in these cells. This study provides the first in vitro evidence of the involvement of HS3ST2 in breast cancer cell invasion and chemosensitivity.Heparan sulfate (HS) proteoglycans (PGs) are proteins containing highly sulfated glycosaminoglycan (GAG) chains. HS is present in all cell types and tissues and functionally interacts with growth factors, tyrosine kinase receptors, matrix metalloproteinases (MMPs) and extracellular matrix (ECM) proteins to modulate cell adhesion, proliferation and motility.1-3 HSPGs do not only regulate physiological processes, such as organogenesis, angiogenesis, blood coagulation and

No abstract

Objectives The purpose of this study was to assess public knowledge on the safety, efficacy, proper storage conditions and other physiochemical properties of different dosage forms. Methods This study was based on a cross-sectional design. A structured quantitative survey, which included five sections, was used as an instrument for data collection. The first section addressed the demographic characteristics of the sample, whereas the second section assessed public knowledge on medications. The third section inquired about participants’ preferred dosage forms. The fourth section was related to the perceived effects of physiochemical properties of medicines on their safety and efficacy. The fifth section addressed participants’ thoughts on appropriate ways for medications usage and storage. A total of 752 participants completed the questionnaire. Data were analysed using SPSS (20.0) software. Key findings Although our study findings pointed out some knowledge gaps based on participants’ answers, most of the participants (87%) reported that physicians or pharmacists were the main sources of their medicine-related information. There was a great variation in participants’ responses regarding perceived onset of action, proper storage conditions and other properties of different dosage forms. Conclusion The study findings demonstrated the need to educate the public about basic information related to different dosage forms of medications.